Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance

BACKGROUND: To evaluate the safety and effectiveness of empagliflozin in routine clinical settings, we collected and assessed the clinical profiles of Korean patients with type 2 diabetes mellitus. METHODS: This was a post-marketing surveillance study of empagliflozin 10 and 25 mg. Information on ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Jun Sung, Kim, Nam Hoon, Na, Jin Oh, Cho, Jae Hyoung, Jeong, In-Kyung, Lee, Soon Hee, Mok, Ji-Oh, Kim, Nan Hee, Chung, Dong Jin, Cho, Jinhong, Lee, Dong Woo, Lee, Sun Woo, Won, Kyu Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925151/
https://www.ncbi.nlm.nih.gov/pubmed/35722684
http://dx.doi.org/10.4093/dmj.2021.0356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925151/
https://www.ncbi.nlm.nih.gov/pubmed/35722684
http://dx.doi.org/10.4093/dmj.2021.0356

Ejemplares similares